R. Arrebola

发表

A Chimeric Subunit of Yeast Transcription Factor IIIC Forms a Subcomplex with τ95

A. Sentenac, H. Voss, M. Riva, 1998, Molecular and Cellular Biology.

A Subunit of Yeast TFIIIC Participates in the Recruitment of TATA-Binding Protein

A. Sentenac, E. Deprez, C. Conesa, 1999, Molecular and Cellular Biology.

Co-existence of circular and multiple linear amplicons in methotrexate-resistant Leishmania.

D. González-Pacanowska, L. Ruiz-Pérez, V. Bernier, 1995, Nucleic acids research.

Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.

P. Reche, D. Santi, E. Garvey, 1994, The Journal of biological chemistry.

Description of a novel eukaryotic deoxyuridine 5'-triphosphate nucleotidohydrolase in Leishmania major.

D. González-Pacanowska, L. Ruiz-Pérez, J. Peña-Diaz, 1997, The Biochemical journal.

Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.

Paul Ferrari, Patrick Mailliet, Hervé Minoux, 2011, Journal of medicinal chemistry.

τ91, an Essential Subunit of Yeast Transcription Factor IIIC, Cooperates with τ138 in DNA Binding

P. Thuriaux, C. Carles, A. Sentenac, 1998, Molecular and Cellular Biology.

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers.

Q. Gao, I. Cornella-Taracido, C. García-echeverría, 2018, Cell chemical biology.

Multiple Roles of the τ131 Subunit of Yeast Transcription Factor IIIC (TFIIIC) in TFIIIB Assembly

J. Acker, A. Sentenac, C. Marck, 2002, Molecular and Cellular Biology.

A mutant dihydrofolate reductase-thymidylate synthase from Leishmania major as a selectable marker in transfection experiments.

D. González-Pacanowska, A. Camacho, R. Arrebola, 1996, Molecular and biochemical parasitology.

SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Joon Sang Lee, C. García-echeverría, L. Debussche, 2020, Molecular Cancer Therapeutics.

MOLECULAR CANCER THERAPEUTICS | SMALL MOLECULE THERAPEUTICS SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Joon Sang Lee, L. Debussche, M. Levit, 2020 .

Expression and characterization of the Trypanosoma cruzi dihydrofolate reductase domain.

P. Reche, D. Santi, D. González-Pacanowska, 1996, Molecular and biochemical parasitology.

Cloning and expression of the dihydrofolate reductase-thymidylate synthase gene from Trypanosoma cruzi.

P. Reche, D. Santi, D. González-Pacanowska, 1994, Molecular and biochemical parasitology.

A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities

R. Gregory, S. Licht, P. Ferrari, 2018, SLAS discovery : advancing life sciences R & D.